MoonLake Immunotherapeutics (NASDAQ: MLTX) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT MOONLAKE IMMUNOTHERAPEUTICS

MoonLake Immunotherapeutics (NASDAQ: MLTX)
Listen to this Section


$19.22
+0.0050 ( +0.03% ) 774.5K

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.

Market Data


Open $19.22
Previous Close $19.21
Volume 774.5K
Market Cap $1.41B
Day Range $19.00 - $19.80
52 Week Range $5.95 - $62.75
Shares Outstanding 73.62M
Change % +0.03%
Net Change ▲ 0.0050
Insider Ownership N/A
Exchange NASDAQ
SectorBasic Materials
IndustryPHARMACEUTICAL PREPARATIONS
IPO Year2022
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: 21,740.00

Date Type Amount Purchased Purchaser
2025-10-09 Buy 10870.00 Bodenstedt Matthias
2025-10-09 Buy 10870.00 Bodenstedt Matthias

SEC Filings


Form Type Description Pages Date
8-k 8K-related 13 Nov 05, 2025
10-q Quarterly Reports 86 Nov 05, 2025
8-k 8K-related 15 Nov 05, 2025
4 Insider transactions 1 Oct 09, 2025
4 Insider transactions 1 Oct 01, 2025
8-k 8K-related 14 Sep 29, 2025
4 Insider transactions 1 Sep 04, 2025
10-q Quarterly Reports 87 Aug 05, 2025
8-k 8K-related 13 Aug 05, 2025
4 Insider transactions 1 Jul 07, 2025

Latest News


× Before browsing our site, please accept our cookies policy